enVVeno Medical Corporation
NVNO
$0.38
-$0.01-3.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M |
| Total Depreciation and Amortization | 494.00K | 503.00K | 509.00K | 528.00K | 540.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.23M | 4.50M | 3.94M | 4.16M | 4.27M |
| Change in Net Operating Assets | 10.00K | 950.00K | -422.00K | 290.00K | -277.00K |
| Cash from Operations | -17.23M | -17.11M | -17.31M | -16.84M | -16.71M |
| Capital Expenditure | -9.00K | -18.00K | -27.00K | -37.00K | -37.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 627.00K | 3.21M | 4.37M | 1.37M | -9.72M |
| Cash from Investing | 618.00K | 3.19M | 4.34M | 1.34M | -9.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 241.00K | 13.59M | 13.59M | 13.64M | 39.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 241.00K | 13.59M | 13.59M | 13.64M | 39.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.37M | -336.00K | 623.00K | -1.87M | 12.97M |